UNSPSC 51382405: Bromfenac sodium sesquihydrate

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula 2C15H11BrNO3.2Na.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8ECV571Y37, chemically known as benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-, monosodium salt, sesquihydrate but more generally known as bromfenac sodium, which bears US NIH Compound Identifier 60725. European Medicines Agency schedules Bromfenac sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00874MIG.

Most nations, for tariff and trade purposes, schedule bromfenac sodium sesquihydrate under HS 29225000. SMILES: C1CC(C(C(C1)C(=O)C2CCC(CC2)BR)N)CC(=O)[O-].C1CC(C(C(C1)C(=O)C2CCC(CC2)BR)N)CC(=O)[O-].O.O.O.[NA+].[NA+].

UNSPSC 51382405 Bromfenac sodium sesquihydrate is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical scope. The single recent opportunity tagged to this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems, products entirely unrelated to bromfenac sodium sesquihydrate, an ophthalmic nonsteroidal anti-inflammatory drug. The mismatch between the code's intended scope and the actual procurement suggests either a data classification error or an opportunistic code application by the issuing body. State and local governments typically purchase bromfenac sodium sesquihydrate through established pharmaceutical supply contracts and group purchasing organizations rather than standalone IFBs, and the recent record does not reflect this typical activity pattern.

Seminole County, Florida posted the naloxone and drug deactivation systems IFB on June 30, 2026, with a response deadline of July 26, 2026, seeking 1,900 units of naloxone and 800 deactivation systems annually on a two-year initial term with a one-year renewal option. Quarterly deliveries are required to the Seminole County Community Health Building in Sanford, with vendors responsible for all shipping and delivery costs. Bidders must comply with drug-free workplace certification, E-Verify requirements, and insurance specifications including workers' compensation and general liability. The procurement does not carry explicit set-aside designations and includes potential FEMA funding with associated federal compliance obligations. Given the code's apparent misclassification and the absence of recent opportunities actually purchasing bromfenac sodium sesquihydrate through state or local channels, this code merits a watch status pending clarification of how the category is being applied by issuing bodies.